Mitochondrial metabolism of pyruvate is required for its enhancement of cardiac function and energetics.
Pyruvate augmentation of contractile function and cytosolic free energy of ATP hydrolysis in myocardium could result from pyruvate catabolism in the mitochondria or from increased ratio of the cytosolic NAD-/NADH redox couple via the lactate dehydrogenase equilibrium.


OBJECTIVE
To test the hypothesis that cytosolic oxidation by pyruvate is sufficient to increase cardiac function and energetics.


METHODS
Isolated working guinea-pig hearts received 0.2 mM octanoate +/- 2.5 mM pyruvate as fuels. alpha-Cyano-3-hydroxycinnamate (COHC, 0.6 mM) was administered to selectively inhibit mitochondrial pyruvate uptake without inhibiting pyruvate's cytosolic redox effects or octanoate oxidation. The effects of pyruvate and COHC on sarcoplasmic reticular- Ca2+ handling were examined in 45Ca-loaded hearts.


RESULTS
Pyruvate increased left ventricular stroke work and power 40%, mechanical efficiency 29%, and cytosolic ATP phosphorylation potential nearly fourfold. 14CO2 formation from [1-14C]pyruvate was inhibited 65% by COHC, and octanoate oxidation, i.e. 14CO2 formation from [1-14C]octanoate, concomitantly increased threefold. COHC prevented pyruvate enhancement of left ventricular function, mechanical efficiency and cytosolic phosphorylation potential, but did not alter respective levels in pyruvate-free control hearts and augmented cytosolic oxidation by pyruvate. Pyruvate increased sarcoplasmic reticular Ca2+ turnover, i.e. Ca2+ uptake and release, as indicated by 62% decrease in caffeine-induced 45Ca release following 40 min 45Ca washout (P < 0.01). In presence of COHC, pyruvate did not lower caffeine-induced 45Ca release; thus. COHC abrogated pyruvate enhancement of Ca2+ turnover (P < 0.001).


CONCLUSIONS
Pyruvate oxidation of cytosolic redox state is not sufficient to increase cardiac function, cytosolic energetics and sarcoplasmic reticular Ca2+ turnover when mitochondrial pyruvate transport is disabled; thus, mitochondrial metabolism of pyruvate is essential for its metabolic inotropism.
Mallet
R T
RT
Department of Integrative Physiology, University of North Texas Health Science Center, Fort Worth 76107-2699, USA. malletr@hsc.unt.edu
Sun
J
J
D000255:Adenosine Triphosphate / Q000378:metabolism; D000704:Analysis of Variance; D000818:Animals; D001692:Biological Transport; D002118:Calcium / Q000378:metabolism; D002210:Caprylates / Q000378:metabolism / Q000494:pharmacology; D003373:Coumaric Acids / Q000494:pharmacology; D003600:Cytosol / Q000378:metabolism; D006168:Guinea Pigs; D008929:Mitochondria, Heart / Q000187:drug effects / Q000378:metabolism*; D009200:Myocardial Contraction; D010477:Perfusion; D010766:Phosphorylation; D019289:Pyruvic Acid / Q000378:metabolism* / Q000494:pharmacology; D012519:Sarcoplasmic Reticulum / Q000187:drug effects / Q000378:metabolism; D013395:Sucrose / Q000378:metabolism
D002210:Caprylates; D003373:Coumaric Acids; C007175:alpha-cyano-4-hydroxycinnamate; D013395:Sucrose; D019289:Pyruvic Acid; D000255:Adenosine Triphosphate; D002118:Calcium